Antineoplastic agents. 454. Synthesis of the strong cancer cell growth inhibitors trans-dihydronarciclasine and 7-deoxy-trans-dihydronarciclasine (1a).
George R Pettit, Sylvie Ducki, Stephen A Eastham, Noeleen Melody
Index: J. Nat. Prod. 72(7) , 1279-82, (2009)
Full Text: HTML
Abstract
To further pursue the antineoplastic leads offered by our isolation of trans-dihydronarciclasine (1a) and 7-deoxy-trans-dihydronarciclasine (1c) from two medicinal plant species of the Amaryllidaceae family, a practical palladium-catalyzed hydrogenation procedure was developed for the synthesis of these isocarbostyrils from narciclasine (2a) and 7-deoxynarciclasine (2c).
Related Compounds
Related Articles:
2012-12-01
[J. Pharm. Biomed. Anal. 71 , 187-92, (2012)]
Seasonal accumulation of major alkaloids in organs of pharmaceutical crop Narcissus Carlton.
2013-04-01
[Phytochemistry 88 , 43-53, (2013)]
[Study on chemical constituents of the bulbs of Lycoris longituba].
2011-09-01
[Zhong Yao Cai 34(9) , 1366-8, (2011)]
Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids.
2009-06-15
[Bioorg. Med. Chem. Lett. 19 , 3233-7, (2009)]
Antineoplastic agents. 550. Synthesis of 10b(s)-epipancratistatin from (+)-narciclasine.
2007-03-01
[J. Nat. Prod. 70(3) , 417-22, (2007)]